Authors:
GASPERICAMPANI A
RONCUZZI L
ZOLI W
LENZI L
GRUPPIONI R
SENSI A
ZINI N
FARABEGOLI F
AMADORI D
Citation: A. Gaspericampani et al., CHROMOSOMAL ALTERATIONS, BIOLOGICAL FEATURES AND IN-VITRO CHEMOSENSITIVITY OF SCLC-R1, A NEW CELL-LINE FROM HUMAN METASTATIC SMALL-CELL LUNG-CARCINOMA, European journal of cancer, 34(5), 1998, pp. 724-730
Authors:
AMADORI D
FRASSINETI GL
DEMATTEIS A
MUSTACCHI G
SANTORO A
CARIELLO S
FERRARI M
NASCIMBEN O
NANNI O
LOMBARDI A
SCARPI E
ZOLI W
Citation: D. Amadori et al., MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Breast cancer research and treatment, 49(3), 1998, pp. 209-217
Authors:
GASPERICAMPANI A
RONCUZZI L
RICOTTI L
LENZI L
GRUPPIONI R
SENSI A
ZINI N
ZOLI W
AMADORI D
Citation: A. Gaspericampani et al., MOLECULAR AND BIOLOGICAL FEATURES OF 2 NEW HUMAN SQUAMOUS AND ADENOCARCINOMA OF THE LUNG-CELL LINES, Cancer genetics and cytogenetics, 107(1), 1998, pp. 11-20
Authors:
BERTONI L
ZOLI W
MUCCIOLO E
RICOTTI L
NERGADZE S
AMADORI D
GIULOTTO E
Citation: L. Bertoni et al., DIFFERENT GENOME ORGANIZATION IN 2 NEW CELL-LINES ESTABLISHED FROM HUMAN GASTRIC-CARCINOMA, Cancer genetics and cytogenetics, 105(2), 1998, pp. 152-159
Authors:
ZOLI W
RICOTTI L
LENZI L
RONCUZZI L
ZINI N
AMADORI D
GRUPPIONI R
SENSI A
GASPERICAMPANI A
Citation: W. Zoli et al., MOLECULAR-GENETICS AND IN-VITRO SENSITIVITY OF A NEW HUMAN CELL-LINE,KKP, FROM A GASTRIC ADENOCARCINOMA, Cancer genetics and cytogenetics, 105(1), 1998, pp. 43-49
Authors:
GASPERICAMPANI A
RONCUZZI L
ZOLI W
AMADORI D
Citation: A. Gaspericampani et al., SAPORIN-6 AND LONIDAMINE IN PRIMARY-CELL CULTURES FROM HUMAN BREAST CARCINOMAS - A SYNERGISTIC EFFECT, Anti-cancer drug design, 12(2), 1997, pp. 91-98
Authors:
ZOLI W
RONCUZZI L
ZINI N
LENZI L
GRUPPIONI R
BARZANTI F
SENSI A
AMADORI D
GASPERICAMPANI A
Citation: W. Zoli et al., ESTABLISHMENT AND CHARACTERIZATION OF 2 NEW CELL-LINES DERIVED FROM HUMAN METASTATIC BREAST CARCINOMAS, Breast cancer research and treatment, 43(2), 1997, pp. 141-151
Authors:
SHATTUCKEIDENS D
OLIPHANT A
MCCLURE M
MCBRIDE C
GUPTE J
RUBANO T
PRUSS D
TAVTIGIAN SV
TENG DHF
ADEY N
STAEBELL M
GUMPPER K
LUNDSTROM R
HULICK M
KELLY M
HOLMEN J
LINGENFELTER B
MANLEY S
FUJIMURA F
LUCE M
WARD B
CANNONALBRIGHT L
STEELE L
OFFIT K
GILEWSKI T
NORTON L
BROWN K
SCHULZ C
HAMPEL H
SCHLUGER A
GIULOTTO E
ZOLI W
RAVAIOLI A
NEVANLINNA H
PYRHONEN S
ROWLEY P
LOADER S
OSBORNE MP
DALY M
TEPLER I
WEINSTEIN PL
SCALIA JL
MICHAELSON R
SCOTT RJ
RADICE P
PIEROTTI MA
GARBER JE
ISAACS C
PESHKIN B
LIPPMAN ME
DOSIK MH
CALIGO MA
GREENSTEIN RM
PILARSKI R
WEBER B
BURGEMEISTER R
FRANK TS
SKOLNICK MH
THOMAS A
Citation: D. Shattuckeidens et al., BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING, JAMA, the journal of the American Medical Association, 278(15), 1997, pp. 1242-1250
Authors:
ZOLI W
RONCUZZI L
FLAMIGNI A
GRUPPIONI R
SENSI A
ZINI N
AMADORI D
GASPERICAMPANI A
Citation: W. Zoli et al., A NEW CELL-LINE FROM HUMAN INFILTRATING DUCTAL CARCINOMA OF THE BREAST - ESTABLISHMENT AND CHARACTERIZATION, Journal of cancer research and clinical oncology, 122(4), 1996, pp. 237-242
Authors:
FRASSINETI GL
ZOLI W
TIENGHI A
RAVAIOLI A
MILANDRI C
GENTILE A
SALZANO E
AMADORI D
Citation: Gl. Frassineti et al., THE SEQUENTIAL ADMINISTRATION OF COMBINED DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER, Seminars in oncology, 23(5), 1996, pp. 22-28
Authors:
AMADORI D
FRASSINETI GL
ZOLI W
MILANDRI C
TIENGHI A
RAVAIOLI A
GENTILE A
SALZANO E
Citation: D. Amadori et al., A PHASE I II STUDY OF SEQUENTIAL DOXORUBICIN AND PACLITAXEL IN THE TREATMENT OF ADVANCED BREAST-CANCER/, Seminars in oncology, 23(5), 1996, pp. 16-22
Authors:
AMADORI D
FRASSINETI GL
ZOLI W
TIENGHI A
RAVAIOLI A
GIUNCHI DC
GENTILE A
SALZANO E
Citation: D. Amadori et al., A PHASE I II STUDY OF PACLITAXEL AND DOXORUBICIN IN THE TREATMENT OF ADVANCED BREAST-CANCER/, Seminars in oncology, 23(1), 1996, pp. 19-23
Authors:
RONCUZZI L
ZOLI W
BAJORKO P
GASPERICAMPANI A
Citation: L. Roncuzzi et al., IN-VITRO POTENTIATION BY LONIDAMINE OF THE SC-RIP SAPORIN-6 EFFECT INA HUMAN METASTATIC BREAST-CANCER CELL-LINE, Anticancer research, 15(3), 1995, pp. 773-776
Authors:
ZOLI W
FLAMIGNI A
FRASSINETI GL
BAJORKO P
DEPAOLA F
MILANDRI C
AMADORI D
GASPERICAMPANI A
Citation: W. Zoli et al., IN-VITRO ACTIVITY OF TAXOL AND TAXOTERE IN COMPARISON WITH DOXORUBICIN AND CISPLATIN ON PRIMARY-CELL CULTURES OF HUMAN BREAST CANCERS, Breast cancer research and treatment, 34(1), 1995, pp. 63-69
Authors:
BRAAKHUIS BJM
HILL BT
DIETEL M
KELLAND LR
AAPRO MS
ZOLI W
LELIEVELD P
Citation: Bjm. Braakhuis et al., IN-VITRO ANTIPROLIFERATIVE ACTIVITY OF DOCETAXEL (TAXOTERE(R)), PACLITAXEL (TAXOL(R)) AND CISPLATIN AGAINST HUMAN TUMOR AND NORMAL BONE-MARROW CELLS, Anticancer research, 14(1A), 1994, pp. 205-208
Authors:
MONTI F
SZYMCZUK S
MOTTA MR
BENINI C
FATTORI PP
PINI E
PASQUINI E
ZOLI W
AMADORI D
RAVAIOLI A
Citation: F. Monti et al., GM-CSF PRODUCTION IN HUMAN ADENOCARCINOMA CELL-LINES, Journal of biological regulators and homeostatic agents, 7(3), 1993, pp. 85-91
Authors:
AMADORI D
BERTONI L
FLAMIGNI A
SAVINI S
DEGIOVANNI C
CASANOVA S
DEPAOLA F
AMADORI A
GIULOTTO E
ZOLI W
Citation: D. Amadori et al., ESTABLISHMENT AND CHARACTERIZATION OF A NEW CELL-LINE FROM PRIMARY HUMAN BREAST-CARCINOMA, Breast cancer research and treatment, 28(3), 1993, pp. 251-260